Rationale for using surrogate markers for adenomyosis lesions in animal models: A narrative review
DOI:
https://doi.org/10.35335/midwifery.v13i5.2124Keywords:
Adenomyosis, Animal Model, Replacement MarkerAbstract
Adenomyosis is a gynecological disease characterized by the invasion of endometrial glands and stroma into the myometrium, often causing symptoms of dysmenorrhea, abnormal uterine bleeding, and infertility. Basic research using animal models is important for understanding the pathogenesis mechanism and evaluating new interventions, but clinical symptoms in humans are difficult to measure directly in experimental animals. Therefore, surrogate markers that can objectively represent the clinical condition are needed. Methods: This literature review was compiled following the PRISMA 2020 guidelines. Articles were searched in PubMed, Scopus, and Web of Science databases for publications from 2015–2025. Inclusion criteria included original research articles (controlled trials, cohort, or cross-sectional studies) written in English, focusing on the use of surrogate markers in animal models of adenomyosis. Review articles, editorials, and publications without DOI were excluded. Results: A total of six primary studies met the inclusion criteria, most of which used the Institute of Cancer Research (ICR) mouse model with neonatal tamoxifen induction. Surrogate markers used can be grouped into three categories: (1) histological markers, such as the depth of myometrial infiltration and the degree of fibrosis (Masson staining, collagen I/IV, α-SMA), (2) functional markers, such as uterine contractility and pain behavior tests (hotplate latency), and (3) molecular markers, such as TGF-β1/p-Smad3, COX-2, TRPV1, NGF, PR-B, OTR, vimentin, and E-cadherin. In addition, several studies have assessed reproductive markers (LIF expression and implantation rate) as fertility surrogates. The results of these studies show a consistent relationship between adenomyosis progression and fibrosis, molecular dysregulation, hyperalgesia, and changes in uterine contractility. Interventions such as resveratrol, anti-platelet, and TGF-β1 neutralizing antibodies have been shown to improve these markers. Surrogate markers in animal models of adenomyosis have proven rational and useful for assessing disease progression and the effects of interventions. Although translational validity to humans is still limited, histological, functional, molecular, and reproductive markers can be an important bridge between basic research and clinical application in adenomyosis.
Downloads
References
Abbott, J. A. (2017). Adenomyosis and Abnormal Uterine Bleeding (AUB-A)-Pathogenesis, diagnosis, and management. Best Practice & Research. Clinical Obstetrics & Gynaecology, 40, 68–81. https://doi.org/10.1016/j.bpobgyn.2016.09.006
Abbott JA. (2017). Adenomyosis and Abnormal Uterine Bleeding (AUB-A)-Pathogenesis, diagnosis, and management. Best Pract Res Clin Obstet Gynaecol, 40, 68–81.
Agustin, K. (2022). HUBUNGAN STATUS GIZI DENGAN KEJADIAN ENDOMETRIOSIS (Studi Analitik Observasional di Rumah Sakit Islam Sultan Agung Semarang). Universitas Islam Sultan Agung.
Agustiningsih, D. (2025). Perlakuan Aktivitas Fisik Pada Hewan Coba Tikus dalam Penelitian Biomedis. UGM PRESS.
Aisa MC, Cappuccini B, Barbati A, & et al. (2016). Biochemical parameters of renal impairment/injury and surrogate markers of nephron number in intrauterine growth-restricted and preterm neonates at 30-40 days of postnatal corrected age. Pediatr Nephrol, 31(12), 2277–2287.
Andriyani, W., Rohmah, M. K., Prajawanti, K. N., Umar, F., Sukma, K. P., & Yuniarsih, W. (2024). BIOMARKER. TOHAR MEDIA.
Ardiana, M. (2025). FLOW-MEDIATED DILATATION (FMD)-Penanda Risiko Kardiovaskular pada Sindrom Kardiometabolik. Airlangga University Press.
Benagiano, G., Brosens, I., & Habiba, M. (2014). Structural and molecular features of the endomyometrium in endometriosis and adenomyosis. Human Reproduction Update, 20(3), 386–402. https://doi.org/10.1093/humupd/dmt052
Biomedik, M. I., & Raharja, F. A. S. (n.d.). GAMBARAN RESEPTIVITAS ENDOMETRIUM PADA PENDERITA ENDOMETRIOSIS (STUDI PERBEDAAN EKSPRESI LEPTIN DAN TGF-BETA 1 PADA PENDERITA ENDOMETRIOSIS DAN NORMAL).
Bulun, S. E. (2022). Endometriosis caused by retrograde menstruation: now demonstrated by DNA evidence. Fertility and Sterility, 118(3), 535–536.
Kay, N., Huang, C.-Y., Shiu, L.-Y., Yu, Y.-C., Chang, Y., Schatz, F., … Huang, S. J. (2020). TGF-β1 Neutralization Improves Pregnancy Outcomes by Restoring Endometrial Receptivity in Mice with Adenomyosis. Reproductive Sciences, 28(3), 877–887. https://doi.org/10.1007/s43032-020-00308-1
Lessey, B. A., & Young, S. L. (2019). Chapter 9 - Structure, Function, and Evaluation of the Female Reproductive Tract. In J. F. Strauss & R. L. B. T.-Y. and J. R. E. (Eighth E. Barbieri (Eds.) (pp. 206-247.e13). Philadelphia: Elsevier. https://doi.org/https://doi.org/10.1016/B978-0-323-47912-7.00009-3
Li, Y., Zhang, D., Jin, B., Xia, L., & Zhang, A. (2021). Proteomic Analysis of Uterine Tissues During Peri-Implantation Period in Mice with Experimentally Induced Adenomyosis that Treated with anti-Ngf: Implications for Cell-Cell Adhesion and Metabolic Processes. Reproductive Sciences (Thousand Oaks, Calif.), 28(1), 207–217. https://doi.org/10.1007/s43032-020-00262-y
Maruyama, S., Imanaka, S., Nagayasu, M., Kimura, M., & Kobayashi, H. (2020). Relationship between adenomyosis and endometriosis; Different phenotypes of a single disease? European Journal of Obstetrics & Gynecology and Reproductive Biology, 253, 191–197. https://doi.org/https://doi.org/10.1016/j.ejogrb.2020.08.019
Pagala, M. A. (2020). Teknologi Biomarka Molekuler. Universitas Halu Oleo Press.
Putra, M. F. A., & Anggraini, M. A. (2022). Adenomyosis: Diagnosis and Treatment. Jurnal Biologi Tropis, 22(4), 1462–1473.
Qu, M., Lu, P., Bellve, K., Lifshitz, L. M., & ZhuGe, R. (2021). Mode Switch of Ca(2 +) Oscillation-Mediated Uterine Peristalsis and Associated Embryo Implantation Impairments in Mouse Adenomyosis. Frontiers in Physiology, 12, 744745. https://doi.org/10.3389/fphys.2021.744745
Shen, M., Liu, X., Zhang, H., & Guo, S.-W. (2016). Transforming growth factor β1 signaling coincides with epithelial-mesenchymal transition and fibroblast-to-myofibroblast transdifferentiation in the development of adenomyosis in mice. Human Reproduction (Oxford, England), 31(2), 355–369. https://doi.org/10.1093/humrep/dev314
Struble, J., Reid, S., & Bedaiwy, M. A. (2016). Adenomyosis: A Clinical Review of a Challenging Gynecologic Condition. Journal of Minimally Invasive Gynecology, 23(2), 164–185. https://doi.org/10.1016/j.jmig.2015.09.018
Struble J, Reid S, & Bedaiwy MA. (2016). Adenomyosis: A Clinical Review of a Challenging Gynecologic Condition. J Minim Invasive Gynecol, 23(2), 164–185.
Tellum, T., & Munro, M. G. (2022). Classifications of adenomyosis and correlation of phenotypes in imaging and histopathology to clinical outcomes: a review. Current Obstetrics and Gynecology Reports, 11(1), 1–11.
Wahyuhadi, J. (2020). Implikasi Klinis Penggunaan Imunoterapi Pada Kasus Glioblastoma. Airlangga University Press.
Zhang L, Rao F, & Setzen R. (2017). High intensity focused ultrasound for the treatment of adenomyosis: selection criteria, efficacy, safety and fertility. Acta Obstet Gynecol Scand, 96(6), 707–714.
Zhu, B., Chen, Y., Shen, X., Liu, X., & Guo, S.-W. (2016). Anti-platelet therapy holds promises in treating adenomyosis: experimental evidence. Reproductive Biology and Endocrinology : RB&E, 14(1), 66. https://doi.org/10.1186/s12958-016-0198-1
Zhu, B., Chen, Y., Zhang, H., Liu, X., & Guo, S.-W. (2015). Resveratrol Reduces Myometrial Infiltration, Uterine Hyperactivity, and Stress Levels and Alleviates Generalized Hyperalgesia in Mice With Induced Adenomyosis. Reproductive Sciences (Thousand Oaks, Calif.), 22(11), 1336–1349. https://doi.org/10.1177/1933719115572479
